Crushed
Newsroom

Business

Trulieve's coming to Austin, Dallas, and San Antonio this fall

The Florida MSO is opening three medical dispensaries in Texas this September under the state's Compassionate Use Program.

By The Crushed Desk · 3d ago · 4 min read

Photo: The Marijuana Herald

Texas medical cannabis is still one of the most restrictive programs in the country, but the map of who can actually get to a dispensary is about to get bigger. Trulieve is planning a September opening for three new locations — Austin, Dallas, and San Antonio — after picking up conditional approval for a Texas Dispensing Organization license back in December.

These aren't small footprints for a state that's historically kept its medical program tight: Austin gets a 4,060-square-foot store with a $250,000 renovation budget, while Dallas and San Antonio are landing smaller locations in the 1,300–2,750-square-foot range with around $200,000 going into buildout each. Trulieve joins Texas Original, goodblend, and Fluent as the operators licensed to serve the state's Compassionate Use Program, which covers patients with intractable epilepsy, MS, autism, PTSD, cancer, and chronic pain.

It's a reminder of just how much of the country is still living somewhere in between full legal access and none at all. Patients in Texas with a qualifying condition have had a legal path to cannabis for years now, but actually getting to a physical store has meant driving to whatever handful of locations existed statewide. Three more storefronts in three of the state's biggest metros is a real, tangible expansion of who can get their medicine without a multi-hour round trip.

For Trulieve, it's also a bet that Texas eventually loosens up further — the company has been steadily building out its footprint in restrictive medical states like Georgia and West Virginia on the theory that being early and vertically integrated pays off whenever a state does decide to expand its program.

Crushed is the home base for cannabis culture: creators, news, local drops, and the data behind the market.

More from the desk

All stories